drugset / Trial / NCT00190892
Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial will assess any efficacious benefit and any safety issues associated with the concomitant use of olanzapine and carbamazepine for the treatment of patients with bipolar I disorder, manic or mixed episodes
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepine | Small molecule | 400 mg | — |
| Subject | Carbamazepine | Small molecule | 1200 mg | — |
| Subject | Olanzapine | Small molecule | 10 mg | — |
| Subject | Olanzapine | Small molecule | 30 mg | — |